TBW04187
Telatinib;17-Demethoxy-17-allylaminogeldanamycin;Tanespimycin;17-Allylaminogeldanamycin;17-AAG;17-(Allylamino) Geldanamycin;17-AAG (Tanespimycin);17-AAG (Tanespimycin, CP 127374, KOS-953, NSC 330507, CNF-101,GLD-36, 17-Allylaminogeldanamycin);[3H]-17-AAG;17AAG;17-AAG (KOS953);17-AAG,17AAG;17-AG;17-AGG;17-allylamino-17-demethoxygeldanamycin;CP 127374;Gld-36;KOS 953;NSC 330507;AYUNIORJHRXIBJ-TXHRRWQRSA-N;Tanespimycin [USAN:INN];HMS1791H16;NSC-330507D;CCRIS 9401;CAS-75747-14-7;NCGC00163424-07;17-(Allylamino)-17-demethoxygeldanamycin;BSPBio_001434;EX-A4668;HMS1361H16;HMS3402H16;NSC-704057;NCGC00163424-01;UNII-4GY0AVT3L4;HMS1989H16;NSC330507;TANESPIMYCIN [WHO-DD];CP-127374;Tanespimycin [USAN];s1141;[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate;Geldanamycin, 17-(Allylamino)-17-demethoxy-;KOS-953;NCGC00163424-06;17-ALLYLAMINO 17-DEMETHOXYGELDANAMYCIN;tanespimycinum;BRD-K81473043-001-08-8;Cp 127374;17-(Allylamino)-17-demethoxygeldanamycin, >=98% (HPLC), solid;Allylamino-17-demethoxygeldanamycin, 17-;CNF1010;TANESPIMYCIN [INN];NCGC00163424-04;HY-10211;Geldanamycin, 17-demethoxy-17-(2-propenylamino)-;CCG-208039;SCHEMBL13037468;4GY0AVT3L4;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate;BRD-K81473043-001-03-9;CNF-101;CNF-1010;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-Hydroxy-8,14-dimethoxy-4,10,12,16- tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo(16.3.1)docosa- 1(21),4,6,10,18-penten-9-yl carbamate;Geldanamycin, 17-allylamino-17-demethoxy-;17-N-allylamino-17-demethoxygeldanamycin;Geldanamycin,17-demethoxy-17-(2-propenylamino)-;CS-0161;17-demethoxy-17-(2-propenylamino)geldanamycin;SCHEMBL16226295;AKOS024456643;SCHEMBL2604976;BMS-722782;tanespimycina;A1-50460;NCGC00163424-02;17-(Allylamino)geldanamycin;CHEBI:94756;C76418;NCGC00163424-05;BDBM50008057;DTXCID3026352;Tox21_112054;MFCD04973892;DB05134;IDI1_033904;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-Hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-penten-9-yl carbamate;Tanespimycin (17-AAG);D06650;CHEBI:64153;17-Demethoxy-17-allylamino geldanamycin;NSC-330507;75747-14-7;J-504153;BCP9000064;DTXSID5046352;Tanespimycin (USAN);Geldanamycin, des-O-methyl-17-allylamino-;[(3R,5S,6R,7S,8E,10S,11S,12Z,14E)-21-(allylamino)-6-hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-17-azabicyclo[16.3.1]docosa-1(21),8,12,14,18-pentaen-10-yl] carbamate;[(3S,5S,6R,7S,8E,10R,11S,12E,14E)-6-Hydroxy-5,11-dimethoxy-3,7,9,15-tetramethyl-16,20,22-trioxo-21-(prop-2-enylamino)-17-azabicyclo[16.3.1]docosa-8,12,14,18,21-pentaen-10-yl] carbamate;tanespimycine
C31H43N3O8
585.69
